ORMP vs QRVO · rev $2.0M vs P/E 27, rev $3.68B
Oramed Pharmaceuticals Inc (ORMP) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported ORMP revenue for 2025-12-31 was $2.0M. Net income was $64.0M. ORMP currently screens at market cap $87.2M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
ORMP currently screens at market cap $87.2M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the ORMP and QRVO stock pages for the full models.
Not investment advice.